GPRC5b通过NF-κB通路调控肾小球疾病炎症反应
该研究通过大规模表达谱分析发现孤儿G蛋白偶联受体Gprc5b在足细胞中高表达,并在糖尿病肾病、IgA肾病和狼疮性肾炎等人类肾小球疾病中显著上调。足细胞特异性Gprc5b敲除小鼠部分抵抗LPS诱导的蛋白尿和炎症细胞浸润,机制涉及NF-κB信号通路。提示GPRC5b可能参与肾小球疾病发病。
要点
- Gprc5b在足细胞高表达,且在糖尿病肾病、IgA肾病和狼疮性肾炎中上调。
- 足细胞特异性Gprc5b敲除不影响肾小球滤过屏障正常发育。
- Gprc5b敲除部分减轻LPS诱导的蛋白尿和炎症细胞募集。
核心结论
- GPRC5b是一种新型足细胞特异性受体,通过调控NF-κB信号通路调节肾小球炎症反应。
- Gprc5b在人类肾小球疾病中上调,提示其可能参与发病过程。
研究设计与样本
- 研究对肾小球相关G蛋白偶联受体进行大规模基因表达谱分析。
- 使用定量PCR、免疫荧光和已发表芯片数据集分析Gprc5b在疾病中的表达。
- 体内研究采用足细胞特异性Gprc5b敲除小鼠品系。
- 机制研究在培养的人足细胞中进行。
主要发现
- Gprc5b在糖尿病肾病、IgA肾病和狼疮性肾炎等常见人类肾小球疾病中显著上调。
- LPS诱导的小鼠肾病中检测到Gprc5b类似上调。
- 足细胞特异性Gprc5b敲除小鼠部分抵抗LPS诱导的蛋白尿和炎症细胞募集。
- Gprc5b敲除小鼠RNA测序和培养人足细胞实验显示Gprc5b通过NF-κB信号调控足细胞炎症反应。
临床怎么用
- GPRC5b可能作为肾小球疾病炎症通路的潜在治疗靶点,但尚未进入临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inflammatory processes play an important role in the pathogenesis of glomerulopathies. Finding novel ways to suppress glomerular inflammation may offer a new way to stop disease progression. However, the molecular mechanisms that initiate and drive inflammation in the glomerulus are still poorly understood. METHODS: We performed large-scale gene expression profiling of glomerulus-associated G protein-coupled receptors (GPCRs) to identify new potential therapeutic targets for glomerulopathies. The expression of Gprc5b in disease was analyzed using quantitative PCR and immunofluorescence, and by analyzing published microarray data sets. In vivo studies were carried out in a podocyte-specific Gprc5b knockout mouse line. Mechanistic studies were performed in cultured human podocytes. RESULTS: We identified an orphan GPCR, Gprc5b, as a novel gene highly enriched in podocytes that was significantly upregulated in common human glomerulopathies, including diabetic nephropathy, IgA nephropathy, and lupus nephritis. Similar upregulation of Gprc5b was detected in LPS-induced nephropathy in mice. Studies in podocyte-specific Gprc5b knockout mice showed that Gprc5b was not essential for normal development of the glomerular filtration barrier. However, knockout mice were partially protected from LPS-induced proteinuria and recruitment of inflammatory cells. Mechanistically, RNA sequencing in Gprc5b knockouts mice and experiments in cultured human podocytes showed that Gpr5cb regulated inflammatory response in podocytes via NF-κB signaling. CONCLUSIONS: GPRC5b is a novel podocyte-specific receptor that regulates inflammatory response in the glomerulus by modulating the NF-κB signaling pathway. Upregulation of Gprc5b in human glomerulopathies suggests that it may play a role in their pathogenesis.
引用
- Zambrano S, Möller-Hackbarth K, Li X, et al. GPRC5b Modulates Inflammatory Response in Glomerular Diseases via NF-κB Pathway. J Am Soc Nephrol. 2019. PMID: 31285284. doi:10.1681/ASN.2019010089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。